Vir Biotechnology Presents New Data Evaluating the
– Data from multiple ongoing trials evaluating Vir’s two novel HBV therapies continue to demonstrate substantial reductions in hepatitis B surface antigen...
Source: globenewswire.com
Stay updated with breaking news from Lap Chee College. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Data from multiple ongoing trials evaluating Vir’s two novel HBV therapies continue to demonstrate substantial reductions in hepatitis B surface antigen...